Luxin Yang

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Feng Zhu, Guoqing Wei, Yandan Liu et al. · Cell Transplantation · 2021 · 35 citations · Full text

Medicine, Infectious Diseases, Oncology +17

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies

Feng Zhu, Guoqing Wei, Mingming Zhang et al. · Cell Transplantation · 2020 · 28 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +14

Liposomal <scp>AntagomiR</scp>‐155‐5p Restores <scp>Anti‐Inflammatory</scp> Macrophages and Improves Arthritis in Preclinical Models of Rheumatoid Arthritis

Audrey Paoletti, Bineta Ly, Catherine Cailleau et al. · Arthritis & Rheumatology · 2023 · 28 citations · Full text

Medicine, Immunology, Pharmacology +17

Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trial

Yi Luo, Lei Gao, Jia‐Bao Liu et al. · EClinicalMedicine · 2023 · 25 citations · Full text

Medicine, Hematology, Immunology +17

Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study

Luxin Yang, Xiaoyu Lai, Ting Yang et al. · Bone Marrow Transplantation · 2023 · 23 citations

Medicine, Hematology, Oncology +17